Inventor · disambiguated record
Andrew Rankin
Also filed as: RANKIN ANDREW · RANKIN ANDREW L
8 granted patents·8 pending applications·1 citations·filing 2010–2024
74Inventor score
Files withFIVE PRIME THERAPEUTICS INC8BRISTOL MYERS SQUIBB CO3REGENERON PHARMA2ALEXION PHARMA INC1MERCK SHARP & DOHME1
Top patents by PatentIndex Score
16 records- 0181US2025206822A1Antibodies Binding to Vista at Acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0279US12195535B2Antibodies binding to VISTA at acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2023·Granted Jan 14, 2025·0 cites·37 claims
- 0377US12173069B2Antibodies binding to vista at acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Dec 24, 2024·1 cites·28 claims
- 0476US12435136B2Antibodies binding to ILT4FIVE PRIME THERAPEUTICS INC·Filed 2022·Granted Oct 7, 2025·0 cites·42 claims
- 0576US2024228653A1PSGL-1 Antagonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 0675US2025129166A1Antibodies Binding to Vista at Acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0768US2022298258A1PSGL-1 Antagonists and Uses ThereofBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0864US11401328B2Antibodies binding to ILT4FIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Aug 2, 2022·0 cites·41 claims
- 0963US11603406B2Antibodies binding to VISTA at acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2018·Granted Mar 14, 2023·0 cites·39 claims
- 1059US11306150B2Method of identifying a P-selectin glycoprotein ligand-1 (PSGL-1) antagonistBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 19, 2022·0 cites·17 claims
- 1152US12091462B2Antibodies binding to vista at acidic pHFIVE PRIME THERAPEUTICS INC·Filed 2019·Granted Sep 17, 2024·0 cites·20 claims
- 1249US2014212412A1Use of il-33 antagonists to treat fibrotic diseaseMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 1345US2021139573A1Dosing regimens for treating or preventing c5-associated diseasesREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 1444US12344665B2Treatment of fibrodysplasia ossificans progressiva by administration of an anti-activin a antibodyREGENERON PHARMA·Filed 2021·Granted Jul 1, 2025·0 cites·17 claims
- 1541US2012263709A1Use of il-33 antagonists to treat fibrotic diseasesRANKIN ANDREW L·Filed 2010·Application pending·0 cites
- 1635US2020038491A1Methods for reducing liver fibrosis and treating lysosomal acid lipase deficiency in patients based on ishak fibrosis stageALEXION PHARMA INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Rankin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →